126 related articles for article (PubMed ID: 1698318)
21. Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling.
Ojcius DM; Zheng LM; Sphicas EC; Zychlinsky A; Young JD
J Immunol; 1991 Jun; 146(12):4427-32. PubMed ID: 2040805
[TBL] [Abstract][Full Text] [Related]
22. Assessment of perforin expression in peripheral blood lymphocytes in psoriatic patients during exacerbation of disease.
Prpić L; Strbo N; Sotosek V; Gruber F; Podack ER; Rukavina D
Acta Derm Venereol Suppl (Stockh); 2000; (211):14-6. PubMed ID: 11234556
[TBL] [Abstract][Full Text] [Related]
23. Perforin and leucocyte cytotoxicity in man.
Lancet; 1990 Oct; 336(8722):1036-7. PubMed ID: 1977024
[No Abstract] [Full Text] [Related]
24. Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
Nakajima F; Khanna A; Xu G; Lagman M; Haschemeyer R; Mouradian J; Wang JC; Stenzel KH; Rubin AL; Suthanthiran M
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7889-93. PubMed ID: 8058730
[TBL] [Abstract][Full Text] [Related]
25. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
Tschopp J; Masson D; Stanley KK
Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
[TBL] [Abstract][Full Text] [Related]
26. Granulated metrial gland cells of pregnant mouse uterus are natural killer-like cells that contain perforin and serine esterases.
Parr EL; Young LH; Parr MB; Young JD
J Immunol; 1990 Oct; 145(7):2365-72. PubMed ID: 1975830
[TBL] [Abstract][Full Text] [Related]
27. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
29. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
30. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
[TBL] [Abstract][Full Text] [Related]
31. Expression of human perforin in a mouse cytotoxic T lymphocyte cell line: evidence for perturbation of granule-mediated cytotoxicity.
Thia KY; Smyth MJ; Trapani JA
J Leukoc Biol; 1993 Dec; 54(6):528-33. PubMed ID: 8245705
[TBL] [Abstract][Full Text] [Related]
32. Perforin binding to cells and lipid membranes determined by a simple competition assay.
Jiang SB; Ojcius DM; Young JD
J Immunol Methods; 1990 Jan; 126(1):29-37. PubMed ID: 2303723
[TBL] [Abstract][Full Text] [Related]
33. Effects of heparin and other acid mucopolysaccharides on the activity of a cytolytic pore-forming protein (perforin) from cytotoxic T-lymphocytes.
Ishiura S; Koizumi H; Tsukahara T; Sugita H
J Biochem; 1988 Jan; 103(1):11-3. PubMed ID: 2966147
[TBL] [Abstract][Full Text] [Related]
34. Cytolytic and ion channel-forming properties of the N terminus of lymphocyte perforin.
Ojcius DM; Persechini PM; Zheng LM; Notaroberto PC; Adeodato SC; Young JD
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4621-5. PubMed ID: 1711204
[TBL] [Abstract][Full Text] [Related]
35. Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones.
Takayama H; Shinohara N; Kawasaki A; Someya Y; Hanaoka S; Kojima H; Yagita H; Okumura K; Shinkai Y
Int Immunol; 1991 Nov; 3(11):1149-56. PubMed ID: 1760409
[TBL] [Abstract][Full Text] [Related]
36. Expression of perforin in murine natural killer cells and cytotoxic T lymphocytes in vivo.
Kawasaki A; Shinkai Y; Yagita H; Okumura K
Eur J Immunol; 1992 May; 22(5):1215-9. PubMed ID: 1577064
[TBL] [Abstract][Full Text] [Related]
37. Homology of perforin to the ninth component of complement (C9).
Shinkai Y; Takio K; Okumura K
Nature; 1988 Aug; 334(6182):525-7. PubMed ID: 3261391
[TBL] [Abstract][Full Text] [Related]
38. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin.
Müller C; Tschopp J
J Immunol; 1994 Sep; 153(6):2470-8. PubMed ID: 7521362
[TBL] [Abstract][Full Text] [Related]
39. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
40. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity.
Lowin B; Beermann F; Schmidt A; Tschopp J
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11571-5. PubMed ID: 7972104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
